Pathogenesis and virulence of Heartland virus
Open Access
- 7 May 2024
- journal article
- review article
- Published by Taylor & Francis in Virulence
- Vol. 15 (1) , 2348252
Abstract
Heartland virus (HRTV), an emerging tick-borne pathogenic bunyavirus, has been a concern since 2012, with an increasing incidence, expanding geographical distribution, and high pathogenicity in the United States. Infection from HRTV results in fever, thrombocytopenia, and leucopenia in humans, and in some cases, symptoms can progress to severe outcomes, including haemorrhagic disease, multi-organ failure, and even death. Currently, no vaccines or antiviral drugs are available for treatment of the HRTV disease. Moreover, little is known about HRTV-host interactions, viral replication mechanisms, pathogenesis and virulence, further hampering the development of vaccines and antiviral interventions. Here, we aimed to provide a brief review of HRTV epidemiology, molecular biology, pathogenesis and virulence on the basis of published article data to better understand this virus and provide clues for further study.Keywords
Funding Information
- National Key Research and Development Program of China (2022YFC2303300)
- Youth Innovation Promotion Association of the Chinese Academy of Sciences (2020333)
- National Natural Science Foundation of China (32170171)
- the Science and Technology Program of Guangzhou, China (202102020057)
- Open Research Fund Program of the State Key Laboratory of Virology of China (2022IOV004)
This publication has 82 references indexed in Scilit:
- Human-to-Human Transmission of Severe Fever With Thrombocytopenia Syndrome Bunyavirus Through Contact With Infectious BloodThe Journal of Infectious Diseases, 2012
- A New Phlebovirus Associated with Severe Febrile Illness in MissouriNew England Journal of Medicine, 2012
- Suppression of the Interferon and NF-κB Responses by Severe Fever with Thrombocytopenia Syndrome VirusJournal of Virology, 2012
- Fever with Thrombocytopenia Associated with a Novel Bunyavirus in ChinaNew England Journal of Medicine, 2011
- Efficient production of Rift Valley fever virus-like particles: The antiviral protein MxA can inhibit primary transcription of bunyavirusesVirology, 2009
- Missorting of LaCrosse Virus Nucleocapsid Protein by the Interferon‐Induced MxA GTPase Involves Smooth ER MembranesTraffic, 2004
- Human MxA Protein Inhibits the Replication of Crimean-Congo Hemorrhagic Fever VirusJournal of Virology, 2004
- Inhibition of Dugbe nairovirus replication by human MxA proteinVirus Research, 2004
- Antivirally active MxA protein sequesters La Crosse virus nucleocapsid protein into perinuclear complexesProceedings of the National Academy of Sciences, 2002
- Expression of Human MxA Protein in Mosquito Cells Interferes with LaCrosse Virus ReplicationJournal of Virology, 2001